| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/28/2001 | DE19963052A1 Topical composition for preventing radiation-induced skin cancer, e.g. due to sunbathing or radiotherapy, containing azole compound such as bifonazole or clotrimazole |
| 06/28/2001 | DE19962936A1 New beta-aminoacid amide derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological disorders e.g. asthma, diabetes or rheumatoid arthritis |
| 06/28/2001 | DE19962329A1 New substituted 2-(phenylaminomethyl)-benzimidazoles, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates |
| 06/28/2001 | DE19962300A1 New N-benzylindolyl glyoxylic acid derivatives are useful as antitumor agents |
| 06/28/2001 | DE19962267A1 Use of combination of nitric oxide synthase inhibitor and ascorbyl compound to strengthen the barrier function of the skin, e.g. for treating dry skin |
| 06/28/2001 | DE19962010A1 Antiviral combination based on dihydropyrimidine derivatives and non-dihydropyrimidine HBV antiviral agents, are useful for treatment of HBV infections |
| 06/28/2001 | DE19961939A1 Nanoscale cationic compounds having specific particle size are useful for the production of cosmetic or pharmaceutical compositions |
| 06/28/2001 | DE19961897A1 Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen Using a film coating as taste coating of pharmaceutical dosage forms |
| 06/28/2001 | DE19961603A1 Production of 2-chlorocyclopropyl-1-chlorophenyl-triazolonyl-propanol derivative, useful as microbicide, from 2-chlorocyclopropyl-2-chlorobenzyl-oxirane |
| 06/28/2001 | DE19960640A1 Neue Stromelysin Inhibitoren New stromelysin inhibitors |
| 06/28/2001 | DE19960204A1 Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Norlbornylamino substituted derivatives, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 06/28/2001 | DE19959913A1 Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne Aspirin-containing transdermal system for the treatment of migraine |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | DE10053003A1 Treatment of immunologically induced skin disorders, skin aging or neuropathy, comprises using peroxisome-proliferator activated receptor, alpha, beta activators such as pirinixic acid |
| 06/28/2001 | CA2717246A1 Use of quinoline and quinolizinone derivatives as chemotherapeutic agents |
| 06/28/2001 | CA2438477A1 An improved process for preparing simvastatin |
| 06/28/2001 | CA2406733A1 Use of parthenolide to inhibit cancer |
| 06/28/2001 | CA2399584A1 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | CA2395520A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 06/28/2001 | CA2395513A1 Methods and compounds for inhibiting mrp1 |
| 06/28/2001 | CA2395471A1 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives |
| 06/28/2001 | CA2395435A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | CA2395411A1 Use of dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
| 06/28/2001 | CA2395300A1 Novel compounds |
| 06/28/2001 | CA2395269A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | CA2395202A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | CA2395200A1 Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease |
| 06/28/2001 | CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | CA2395136A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | CA2395113A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | CA2395109A1 1,1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane |
| 06/28/2001 | CA2395108A1 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 06/28/2001 | CA2394997A1 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 06/28/2001 | CA2394901A1 Chitosan biopolymer for the topical delivery of active agents |
| 06/28/2001 | CA2394864A1 Novel compounds |
| 06/28/2001 | CA2394860A1 Hypodermic needle with weeping tip and method of use |
| 06/28/2001 | CA2394852A1 Substituted pyrroles |
| 06/28/2001 | CA2394834A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2394743A1 Inhibition of .beta.arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia |
| 06/28/2001 | CA2394633A1 Therapeutic and/or prophylactic agent for nervous system disorder |
| 06/28/2001 | CA2394624A1 Method for making 24(s)-hydroxyvitamin d2 |
| 06/28/2001 | CA2394604A1 Substituted acylhydroxamic acids and method of reducing tnf.alpha. levels |
| 06/28/2001 | CA2394603A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | CA2394568A1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 06/28/2001 | CA2394524A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy |
| 06/28/2001 | CA2394330A1 Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and at least a component selected from a na+/h+ exchanger inhibitors, cyclo-oxygenase inhibitors and caspase inhibitors |
| 06/28/2001 | CA2394222A1 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 06/28/2001 | CA2394139A1 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 06/28/2001 | CA2394095A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | CA2394015A1 Tweak receptor |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393837A1 Use of desloratadine for treating allergic and inflammatory conditions in pediatric patients |
| 06/28/2001 | CA2393756A1 Potassium channel inhibitors |
| 06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | CA2393646A1 Survivin promotion of angiogenesis |
| 06/28/2001 | CA2393367A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2393363A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2393359A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 06/28/2001 | CA2392873A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2392554A1 Inhibitors of thrombin induced platelet aggregation |
| 06/28/2001 | CA2392150A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | CA2392127A1 Tryptase inhibitors |
| 06/28/2001 | CA2392121A1 Tryptase inhibitors |
| 06/28/2001 | CA2391374A1 Il-17 homologous polypeptides and therapeutic uses thereof |
| 06/28/2001 | CA2389482A1 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
| 06/28/2001 | CA2389479A1 Butyne diol derivatives |
| 06/28/2001 | CA2388669A1 Inhibitors of farnesyl protein transferase |
| 06/28/2001 | CA2387579A1 Farnesyl transferase inhibitors |
| 06/28/2001 | CA2384326A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | CA2384110A1 Treatment of viral infections using levovirintm |
| 06/28/2001 | CA2363837A1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 06/27/2001 | EP1111390A1 Method for evaluating lipid a analog-containing injections |
| 06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
| 06/27/2001 | EP1110960A1 Apoptosis inducing agents |
| 06/27/2001 | EP1110958A1 Alpha-arylethylpiperazine derivatives as neurokinin antagonists |
| 06/27/2001 | EP1110957A1 Benzazole derivatives and their use as JNK modulators |
| 06/27/2001 | EP1110954A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 06/27/2001 | EP1110953A1 Quinazoline derivatives |
| 06/27/2001 | EP1110952A1 Carboxylic acid derivates, their preparation and use |
| 06/27/2001 | EP1110949A1 EP4 receptor selective agonists in the treatment of osteoporosis |
| 06/27/2001 | EP1110909A1 Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use |
| 06/27/2001 | EP1110556A1 Preventives/remedies for multiple organ failure |
| 06/27/2001 | EP1110554A1 Medicinal compositions for treating eye diseases |
| 06/27/2001 | EP1110553A1 Sustained release oral preparations of fasudil hydrochloride |
| 06/27/2001 | EP1110551A2 Ocular tension lowering agent |
| 06/27/2001 | EP1110550A2 Composition comprising ascorbic acid and pectin |
| 06/27/2001 | EP1110549A1 Use of trimebutine for treating pain |
| 06/27/2001 | EP1110548A1 Substances having antiobese and visceral fat-reducing functions and utilization thereof |
| 06/27/2001 | EP1110545A2 Pharmaceutical preparations for the targeted treatment of Morbus Crohn and Colitis Ulcerosa |
| 06/27/2001 | EP1110544A2 Use of a film coating as taste masking coating for oral dosage forms |
| 06/27/2001 | EP1110543A2 Extended release oral dosage composition |
| 06/27/2001 | EP1110542A2 Once-a-day metoprolol oral dosage form |
| 06/27/2001 | EP1110540A1 Melt granulated sucralfate preparations |
| 06/27/2001 | EP1110539A1 Use of 3,3',5,5'-tetrahehydroxystilbene as a glycation inhibitor |
| 06/27/2001 | EP1110537A2 Cosmetic composition comprising N-ethoxycarbonyl-4-aminophenol and arbutin or its derivatives and/or ellagic acid or its derivatives |
| 06/27/2001 | EP1109924A2 Methylation of plasmid vectors |
| 06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |
| 06/27/2001 | EP1109908A2 Leptin induced genes |
| 06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |